Question & AnswerQ&A (Act No. 3073)
The main purpose of Act No. 3073 is to regulate the sale, barter, exchange, and distribution of viruses, serums, toxins, antitoxins, and analogous products in the Philippine Islands to ensure public health safety.
Any person, firm, or corporation who sells, barters, or exchanges viruses, serums, toxins, antitoxins, or analogous products must hold an unsuspended and unrevoked license issued by the Secretary of Public Instruction upon recommendation of the Director of Health.
Each package must be plainly marked with the proper name of the article contained, the name, address, and license number of the manufacturer, and the expiration date beyond which the contents cannot be expected to reliably yield their specific results.
No, except for stock that has been sold and delivered by the licensee prior to suspension or revocation, unless the owner or custodian has been notified by the Secretary of Public Instruction not to sell, barter, or exchange such products.
Falsifying, relabeling, remarking, or altering any label or mark on any package or container of any virus, serum, toxin, antitoxin, or analogous product to falsify such label or mark is prohibited.
Officers, agents, or employees of the Bureau of Health duly authorized by the Director of Health may enter and inspect any establishment for the safeguarding of public health.
The board is composed of the Secretary of Public Instruction as chairman, and the Director of Health and the Director of the Bureau of Science as members.
The board has the authority to promulgate rules necessary to govern the issuance, suspension, and revocation of licenses for the propagation and preparation of viruses, serums, toxins, antitoxins, and analogous products.
Violators may be punished by a fine not exceeding one thousand pesos, or imprisonment not exceeding one year, or both, at the discretion of the court.
The Secretary of Public Instruction is authorized and directed to issue, suspend, or revoke licenses for the propagation and preparation of viruses, serums, toxins, antitoxins, and analogous products upon recommendation of the Director of Health.